PharmaCyte Biotech (Formerly Known As Nuvilex)
1971 Old Cuthbert Road
Cherry Hill
New Jersey
08034
United States
Tel: 856-433-6088
Fax: 856-354-1077
Website: http://www.nuvilex.com/
Email: info@nuvilex.com
375 articles about PharmaCyte Biotech (Formerly Known As Nuvilex)
-
Nuvilex's Subsidiary, Medical Marijuana Sciences, Inc., to Develop Disease Treatments Based on Cannabinoids
2/12/2013
-
Nuvilex's Subsidiary Files International Patent for All-Natural Flu Virus Treatment
1/15/2013
-
Nuvilex COO Highlights Advantages and Applications of Platform Cell Encapsulation Technology for Cancer, Diabetes, and Stem Cells During Recent Interview With SmallSector.com
12/18/2012
-
Nuvilex Reports Additional Safety and Efficacy Data From Second Phase 2 Pancreatic Cancer Trial
10/8/2012
-
Nuvilex Subsidiary Austrianova Singapore to Participate in AusBiotech 2012
10/2/2012
-
Nuvilex's Subsidiary, Austrianova Singapore, to Provide Confirmatory Findings From Additional Pancreatic Cancer Trial Data at ISCGT Meeting
9/27/2012
-
Nuvilex Cleared to Enter Multi Billion Dollar Cosmetics Industry
9/6/2012
-
Nuvilex's President and CEO in Singapore for Meetings With Its Subsidiary Austrianova Singapore
8/24/2012
-
Nuvilex Endorses Proposed Congressional Legislation on Pancreatic Cancer Initiative
8/16/2012
-
Nuvilex Subsidiary Austrianova Singapore's Cancer Treatments Featured in Asia's Leading Biotech Industry Magazine
8/9/2012
-
Nuvilex Announces Substantial Development in Pancreatic Cancer Research
7/17/2012
-
Nuvilex Finalizes Asset Purchase Agreement and Completes Acquisition of SG Austria Assets
6/28/2012
-
Nuvilex Announces Excitement Grows in Japan over Encapsulated Living Cell Technology Oncological Applications
5/8/2012
-
Nuvilex Retains Dawson James Financial Services and Moves to Finalize SG Austria Asset Acquisition
5/1/2012
-
Nuvilex Release: KonLin Letter Cites Clinical Trials and Future Partnerships as Rationale for its Projection of Strong Future Revenue
4/23/2012
-
Nuvilex Release: April 2012 KonLin Letter Cites Cutting-Edge Technology for Stem Cells and Treatments for Cancer and Diabetes, and Reaffirms Buy Recommendation
4/20/2012
-
Nuvilex Announces Invitation to Showcase Innovative Therapy for Cancer Treatment at Oncology Meeting in Kyoto, Japan
4/18/2012
-
Nuvilex Announces Further Enhancement of Patent Position
4/11/2012
-
Nuvilex Release: Therapeutic Antibody Producing Cells Encapsulated Using Cell-in-a-Box® Encapsulation Technology Proven Effective for Targeted Treatment of Various Diseases
4/3/2012
-
Nuvilex Announces Advance in Gene Therapy for Encapsulated Living Cells Using Magnetic Nanoparticles
3/26/2012